221 related articles for article (PubMed ID: 33402562)
1. S100A2: A potential biomarker to differentiate malignant from tuberculous pleural effusion.
Wang T; Wang N; Zhang L; Liu Y; Thakur A
Indian J Cancer; 2021; 58(2):241-247. PubMed ID: 33402562
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of periostin in lung cancer-related malignant pleural effusion.
Zhang J; Zha T; Zhang N; Sun G
J Clin Lab Anal; 2022 Feb; 36(2):e24179. PubMed ID: 35152510
[TBL] [Abstract][Full Text] [Related]
3. Potential biomarkers for antidiastole of tuberculous and malignant pleural effusion by proteome analysis.
Shi J; Li P; Zhou L; Qi S; Wang B; Li D; Duan L; Chen WX; Xia J; Zou L; Yang S
Biomark Med; 2019 Feb; 13(2):123-133. PubMed ID: 30791695
[TBL] [Abstract][Full Text] [Related]
4. Procalcitonin as a diagnostic marker in differentiating parapneumonic effusion from tuberculous pleurisy or malignant effusion.
Lee SH; Lee EJ; Min KH; Hur GY; Lee SY; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Lee SY
Clin Biochem; 2013 Oct; 46(15):1484-8. PubMed ID: 23570862
[TBL] [Abstract][Full Text] [Related]
5. Monocytes subtypes from pleural effusion reveal biomarker candidates for the diagnosis of tuberculosis and malignancy.
Luo L; Deng S; Tang W; Hu X; Yin F; Ge H; Tang J; Liao Z; Feng J; Li X; Mo B
J Clin Lab Anal; 2022 Aug; 36(8):e24579. PubMed ID: 35819097
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in differentiating malignant from benign pleural effusion.
Dong J; Sun G; Zhu H
Tumour Biol; 2016 Mar; 37(3):3257-64. PubMed ID: 26438059
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic significance of S100A2 and S100A6 levels in sera of patients with non-small cell lung cancer.
Wang T; Liang Y; Thakur A; Zhang S; Yang T; Chen T; Gao L; Chen M; Ren H
Tumour Biol; 2016 Feb; 37(2):2299-304. PubMed ID: 26361956
[TBL] [Abstract][Full Text] [Related]
8. Differentiating Malignant from Tubercular Pleural Effusion by Cancer Ratio Plus (Cancer Ratio: Pleural Lymphocyte Count).
Verma A; Dagaonkar RS; Marshall D; Abisheganaden J; Light RW
Can Respir J; 2016; 2016():7348239. PubMed ID: 28070157
[No Abstract] [Full Text] [Related]
9. [The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion].
Wei F; Wei Y; Li LF; Li GL; Wang GJ
Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):524-527. PubMed ID: 28728299
[No Abstract] [Full Text] [Related]
10. Identification of differentially expressed miRNAs in differentiating benign from malignant pleural effusion.
Bao Q; Xu Y; Ding M; Chen P
Hereditas; 2020 Feb; 157(1):6. PubMed ID: 32102688
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and prognostic significance of survivin levels in malignant pleural effusion.
Görgün D; Seçik F; Midilli K; Akkaya V; Yıldız P
Respir Med; 2013 Aug; 107(8):1260-5. PubMed ID: 23791464
[TBL] [Abstract][Full Text] [Related]
12. Cell origins and diagnostic accuracy of interleukin 27 in pleural effusions.
Yang WB; Liang QL; Ye ZJ; Niu CM; Ma WL; Xiong XZ; Du RH; Zhou Q; Zhang JC; Shi HZ
PLoS One; 2012; 7(7):e40450. PubMed ID: 22792330
[TBL] [Abstract][Full Text] [Related]
13. Novel clinical biomarkers in blood and pleural effusion for diagnosing patients with tuberculosis distinguishing from malignant tumor.
Wang J; Feng ZX; Ren T; Meng WY; Khan I; Fan XX; Pan HD; Liu L; Tang YJ; Yao XJ; Li RZ; Wang MF; Leung EL
Medicine (Baltimore); 2022 Oct; 101(41):e31027. PubMed ID: 36254028
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic role of interleukin -33 in the differentiation of pleural effusions especially tuberculous and malignant effusions.
Al-Aarag AH; Kamel MH; Abdelgawad ER; Abo-Youssef SM; Moussa HH; Elnaggar ME; Hendy RM; Diab KA
BMC Pulm Med; 2019 Jun; 19(1):114. PubMed ID: 31238901
[TBL] [Abstract][Full Text] [Related]
15. Assessment of a panel of miRNAs in serum and pleural fluid for the differential diagnosis of malignant and benign pleural effusion.
Zhu LR; Yuan RX; Xia XB; Wang Y; Zhu YM; Fi L; Li J
Cancer Biomark; 2022; 33(1):71-82. PubMed ID: 34366325
[TBL] [Abstract][Full Text] [Related]
16. Differences in
Xie T; Wang Q; Gao J; He K; Yu J
Ann Clin Lab Sci; 2024 Mar; 54(2):201-210. PubMed ID: 38802158
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of pleural effusion Krebs von den Lungen-6 in malignant pleural effusion of patients with non-small cell lung cancer.
Wang J; Ling L; Chen S; Chou L; Wang Y; Hu L
Lab Med; 2024 May; 55(3):271-276. PubMed ID: 37566516
[TBL] [Abstract][Full Text] [Related]
18. Validity of procalcitonin and C-reactive protein measurement when differentiating between benign and malignant pleural effusion.
Botana-Rial M; Casado-Rey P; Leiro-Fernández V; Andrade-Olivié M; Represas-Represas C; Fernández-Villar A
Clin Lab; 2011; 57(5-6):373-8. PubMed ID: 21755828
[TBL] [Abstract][Full Text] [Related]
19. Pleural fluid adenosine deaminase to serum C-reactive protein ratio for diagnosing tuberculous pleural effusion.
Rabbi MF; Ahmed MN; Patowary MSA; Huq SR; Razzaque SMA; Arafat HM; Nahar T; Iktidar MA
BMC Pulm Med; 2023 Sep; 23(1):349. PubMed ID: 37715196
[TBL] [Abstract][Full Text] [Related]
20. Superoxide dismutase 2 as a marker to differentiate tuberculous pleural effusions from malignant pleural effusions.
Wang M; Zhang Z; Wang X
Clinics (Sao Paulo); 2014; 69(12):799-803. PubMed ID: 25627990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
